ESMO® 2026 Highlights: Presenter Vignettes – Mark Hull

Dr. Mark Hull

Mark Hull

PhD, FRCP

Leeds Institute of Medical Research

LBA30

Omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) versus placebo after resection of colorectal cancer liver metastases (EMT2): A multicentre, double-blind, randomised phase 3 trial